Recombinant Human Complement C2 protein (rFc Tag)
ED50
/
Species
Human
Purity
>90 %, SDS-PAGE
GeneID
717
Accession
P06681-1
验证数据展示
Technical Specifications
Purity | >90 %, SDS-PAGE |
Endotoxin Level | <1.0 EU/μg protein, LAL method |
Biological Activity |
Not tested |
Source | HEK293-derived Human Complement C2 protein Ala21-Leu752 (Accession# P06681-1) with a rabbit IgG Fc tag at the C-terminus. |
Predicted Molecular Mass | 107.1 kDa |
SDS-PAGE | 90-125 kDa, reducing (R) condition |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Complement C2 is one of the serum glycoproteins in the classical and MBL pathways of complement activation. C2 is made up of three globular domains. The N-terminal domain, which constitutes the C2b segment, is made up of three short consensus repeats (SCRs). C2 deficiency carries an increased risk of developing systemic lupus erythematosus, recurrent infections and atherosclerosis.
References:
1. Tange CE, et al. (2018). Clin Chem Lab Med. Aug 28;56(9):1498-1506. 2. Huda R, et al. (2013). J Autoimmun. May;42:94-104. 3. Budding K, , et al. (2021). Neurol Neuroimmunol Neuroinflamm. Nov 10;9(1):e1107. 4. Laich A, et al. (2022). Immunobiology. May;227(3):152225.